Skip to main content
iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
7.42
+0.20 (2.77%)
At close: Dec 20, 2024, 4:00 PM
7.45
+0.03 (0.41%)
After-hours: Dec 20, 2024, 7:29 PM EST

iTeos Therapeutics Revenue

iTeos Therapeutics had revenue of $35.00M in the twelve months ending September 30, 2024, down -47.37% year-over-year. In the year 2023, iTeos Therapeutics had annual revenue of $12.60M, down -95.29%.

Revenue (ttm)
$35.00M
Revenue Growth
-47.37%
P/S Ratio
8.19
Revenue / Employee
$222,930
Employees
157
Market Cap
271.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202312.60M-255.04M-95.29%
Dec 31, 2022267.63M-77.15M-22.38%
Dec 31, 2021344.78M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TruBridge 337.67M
Lifecore Biomedical 128.44M
AC Immune 48.51M
Senseonics Holdings 22.21M
ProQR Therapeutics 20.51M
Lexicon Pharmaceuticals 5.23M
aTyr Pharma 235.00K
4D Molecular Therapeutics 17.00K
Revenue Rankings

ITOS News

More News